0
     

Report Added
Report already added
Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific digital PCR (dPCR) market will grow by 15.2% annually with a total addressable market cap of $1,699.2 million over 2022-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.

Highlighted with 29 tables and 49 figures, this 104-page report “Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital PCR (dPCR) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital PCR (dPCR) market in every aspect of the classification from perspectives of Offering, Technology, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments & Accessories
•Reagents & Consumables
•Software & Services

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Droplet Digital PCR
•Chip-based Digital PCR
•Beaming Digital PCR
•Other Technologies

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Research
•Clinical Diagnostics
oInfectious diseases
oOncology
oGenetic Disorders
oOther Indications
•Forensic Testing
•Food and Agriculture
•Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Hospitals and Clinics
•Pharma & Biotech Companies
•Diagnostic Centers
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Technology, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
4basebio AG
Bio-Rad Laboratories, Inc.
Combinati, Inc.
Fluidigm Corporation
Formulatrix Inc.
JN Medsys
Merck KGaA
Qiagen N.V
RainDance Technologies
Stilla Technologies Inc.
Sysmex Corporation
Thermo Fisher Scientific, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market22
2.2 Major Growth Drivers24
2.3 Market Restraints and Challenges30
2.4 Emerging Opportunities and Market Trends33
2.5 Porter’s Fiver Forces Analysis37
3 Segmentation of Asia Pacific Market by Offering41
3.1 Market Overview by Offering41
3.2 Instruments & Accessories43
3.3 Reagents & Consumables44
3.4 Software & Services45
4 Segmentation of Asia Pacific Market by Technology46
4.1 Market Overview by Technology46
4.2 Droplet Digital PCR48
4.3 Chip-based Digital PCR49
4.4 Beaming Digital PCR50
4.5 Other Technologies51
5 Segmentation of Asia Pacific Market by Application52
5.1 Market Overview by Application52
5.2 Research54
5.3 Clinical Diagnostics55
5.3.1 Infectious diseases57
5.3.2 Oncology58
5.3.3 Genetic Disorders59
5.3.4 Other Indications60
5.4 Forensic Testing61
5.5 Food and Agriculture62
5.6 Other Applications63
6 Segmentation of Asia Pacific Market by End User64
6.1 Market Overview by End User64
6.2 Hospitals and Clinics66
6.3 Pharma & Biotech Companies67
6.4 Diagnostic Centers68
6.5 Other End Users69
7 Asia-Pacific Market 2021-2031 by Country70
7.1 Overview of Asia-Pacific Market70
7.2 Japan73
7.3 China76
7.4 Australia79
7.5 India81
7.6 South Korea83
7.7 Rest of APAC Region85
8 Competitive Landscape87
8.1 Overview of Key Vendors87
8.2 New Product Launch, Partnership, Investment, and M&A90
8.3 Company Profiles91
4basebio AG91
Bio-Rad Laboratories, Inc.93
Combinati, Inc.94
Fluidigm Corporation95
Formulatrix Inc.96
JN Medsys97
Merck KGaA98
Qiagen N.V99
RainDance Technologies100
Stilla Technologies Inc.101
Sysmex Corporation102
Thermo Fisher Scientific, Inc.103
RELATED REPORTS104

List of Tables:

Table 1. Snapshot of Asia Pacific Digital PCR Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Health Spending by Region, $ bn, 2013-202029
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Digital PCR Market33
Table 5. Asia Pacific Digital PCR Market by Offering, 2021-2031, $ mn41
Table 6. Asia Pacific Digital PCR Market by Technology, 2021-2031, $ mn46
Table 7. Asia Pacific Digital PCR Market by Application, 2021-2031, $ mn52
Table 8. Asia Pacific Digital PCR Market: Clinical Diagnostics by Indication, 2021-2031, $ mn56
Table 9. Asia Pacific Digital PCR Market by End User, 2021-2031, $ mn64
Table 10. APAC Digital PCR Market by Country, 2021-2031, $ mn71
Table 11. Japan Digital PCR Market by Offering, 2021-2031, $ mn75
Table 12. Japan Digital PCR Market by Technology, 2021-2031, $ mn75
Table 13. Japan Digital PCR Market by Application, 2021-2031, $ mn75
Table 14. China Digital PCR Market by Offering, 2021-2031, $ mn77
Table 15. China Digital PCR Market by Technology, 2021-2031, $ mn77
Table 16. China Digital PCR Market by Application, 2021-2031, $ mn77
Table 17. Australia Digital PCR Market by Offering, 2021-2031, $ mn80
Table 18. Australia Digital PCR Market by Technology, 2021-2031, $ mn80
Table 19. Australia Digital PCR Market by Application, 2021-2031, $ mn80
Table 20. India Digital PCR Market by Offering, 2021-2031, $ mn82
Table 21. India Digital PCR Market by Technology, 2021-2031, $ mn82
Table 22. India Digital PCR Market by Application, 2021-2031, $ mn82
Table 23. South Korea Digital PCR Market by Offering, 2021-2031, $ mn84
Table 24. South Korea Digital PCR Market by Technology, 2021-2031, $ mn84
Table 25. South Korea Digital PCR Market by Application, 2021-2031, $ mn84
Table 26. Digital PCR Market in Rest of APAC by Country/Region, 2021-2031, $ mn86
Table 27. 4basebio AG: Company Snapshot91
Table 28. 4basebio AG: Business Segmentation92
Table 29. 4basebio AG: Product Portfolio92

Report Title: Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline